Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al

Saved in:
Bibliographic Details
Published in:Maturitas 2017-08, Vol.102, p.76-77
Main Authors: Anagnostis, Panagiotis, Paschou, Stavroula A, Mintziori, Gesthimani, Ceausu, Iuliana, Depypere, Herman, Lambrinoudaki, Irene, Mueck, Alfred, Pérez-López, Faustino R, Rees, Margaret, Senturk, Levent M, Simoncini, Tommaso, Stevenson, John C, Stute, Petra, Trémollieres, Florence A, Goulis, Dimitrios G
Format: Article
Language:English
Subjects:
Internal Medicine
Obstetrics and Gynecology
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c372t-f62c8c7c4f335325233cb8dad21c30d1216abb617512ef13a8ff143a123c0e973
container_end_page 77
container_issue
container_start_page 76
container_title Maturitas
container_volume 102
creator Anagnostis, Panagiotis
Paschou, Stavroula A
Mintziori, Gesthimani
Ceausu, Iuliana
Depypere, Herman
Lambrinoudaki, Irene
Mueck, Alfred
Pérez-López, Faustino R
Rees, Margaret
Senturk, Levent M
Simoncini, Tommaso
Stevenson, John C
Stute, Petra
Trémollieres, Florence A
Goulis, Dimitrios G
description
doi_str_mv 10.1016/j.maturitas.2017.04.019
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1896894374</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0378512217305741</els_id><sourcerecordid>1896894374</sourcerecordid><originalsourceid>FETCH-LOGICAL-c372t-f62c8c7c4f335325233cb8dad21c30d1216abb617512ef13a8ff143a123c0e973</originalsourceid><addsrcrecordid>eNqNkU2P1DAMhisEYoeFvwA5cmmJk7TpcECaXfEljYTExzlKU1ebmTaZjVOk-fe0mmUPnDhYvryv7fdxUbwBXgGH5t2hmmyek8-WKsFBV1xVHLZPig20WpYKAJ4WGy51W9YgxFXxgujAOa-5VM-LK9GqVkrVbIr7G0-nu7hWsBmJxcR6DJHmyXas9-RiyD7MNvsYmA09S56OLA5sSNYtJyC9Z9-RTjEQshxZvkO2x5wxse7MdsHScqMf7dETw8zs-LJ4NtiR8NVDvy5-ffr48_ZLuf_2-evtbl86qUUuh0a41mmnBilrKWohpeva3vYCnOQ9CGhs1zWgl3w4gLTtMICSFoR0HLdaXhdvL3NPKd7PSNlMSxocRxswzmSg3TbtVkmtFqm-SF2KRAkHc0p-sulsgJuVtzmYR95m5W24Mgvvxfn6YcncTdg_-v4CXgS7iwCXqL89JkPOY3DY-4Qumz76_1jy4Z8ZbvTBOzse8Yx0iHMKC0kDhoTh5sf69vXroCWvtQL5B4nKrGs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1896894374</pqid></control><display><type>article</type><title>Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Anagnostis, Panagiotis ; Paschou, Stavroula A ; Mintziori, Gesthimani ; Ceausu, Iuliana ; Depypere, Herman ; Lambrinoudaki, Irene ; Mueck, Alfred ; Pérez-López, Faustino R ; Rees, Margaret ; Senturk, Levent M ; Simoncini, Tommaso ; Stevenson, John C ; Stute, Petra ; Trémollieres, Florence A ; Goulis, Dimitrios G</creator><creatorcontrib>Anagnostis, Panagiotis ; Paschou, Stavroula A ; Mintziori, Gesthimani ; Ceausu, Iuliana ; Depypere, Herman ; Lambrinoudaki, Irene ; Mueck, Alfred ; Pérez-López, Faustino R ; Rees, Margaret ; Senturk, Levent M ; Simoncini, Tommaso ; Stevenson, John C ; Stute, Petra ; Trémollieres, Florence A ; Goulis, Dimitrios G</creatorcontrib><identifier>ISSN: 0378-5122</identifier><identifier>EISSN: 1873-4111</identifier><identifier>DOI: 10.1016/j.maturitas.2017.04.019</identifier><identifier>PMID: 28483346</identifier><language>eng</language><publisher>Ireland: Elsevier B.V</publisher><subject>Internal Medicine ; Obstetrics and Gynecology</subject><ispartof>Maturitas, 2017-08, Vol.102, p.76-77</ispartof><rights>2017</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c372t-f62c8c7c4f335325233cb8dad21c30d1216abb617512ef13a8ff143a123c0e973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28483346$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Anagnostis, Panagiotis</creatorcontrib><creatorcontrib>Paschou, Stavroula A</creatorcontrib><creatorcontrib>Mintziori, Gesthimani</creatorcontrib><creatorcontrib>Ceausu, Iuliana</creatorcontrib><creatorcontrib>Depypere, Herman</creatorcontrib><creatorcontrib>Lambrinoudaki, Irene</creatorcontrib><creatorcontrib>Mueck, Alfred</creatorcontrib><creatorcontrib>Pérez-López, Faustino R</creatorcontrib><creatorcontrib>Rees, Margaret</creatorcontrib><creatorcontrib>Senturk, Levent M</creatorcontrib><creatorcontrib>Simoncini, Tommaso</creatorcontrib><creatorcontrib>Stevenson, John C</creatorcontrib><creatorcontrib>Stute, Petra</creatorcontrib><creatorcontrib>Trémollieres, Florence A</creatorcontrib><creatorcontrib>Goulis, Dimitrios G</creatorcontrib><title>Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al</title><title>Maturitas</title><addtitle>Maturitas</addtitle><subject>Internal Medicine</subject><subject>Obstetrics and Gynecology</subject><issn>0378-5122</issn><issn>1873-4111</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNqNkU2P1DAMhisEYoeFvwA5cmmJk7TpcECaXfEljYTExzlKU1ebmTaZjVOk-fe0mmUPnDhYvryv7fdxUbwBXgGH5t2hmmyek8-WKsFBV1xVHLZPig20WpYKAJ4WGy51W9YgxFXxgujAOa-5VM-LK9GqVkrVbIr7G0-nu7hWsBmJxcR6DJHmyXas9-RiyD7MNvsYmA09S56OLA5sSNYtJyC9Z9-RTjEQshxZvkO2x5wxse7MdsHScqMf7dETw8zs-LJ4NtiR8NVDvy5-ffr48_ZLuf_2-evtbl86qUUuh0a41mmnBilrKWohpeva3vYCnOQ9CGhs1zWgl3w4gLTtMICSFoR0HLdaXhdvL3NPKd7PSNlMSxocRxswzmSg3TbtVkmtFqm-SF2KRAkHc0p-sulsgJuVtzmYR95m5W24Mgvvxfn6YcncTdg_-v4CXgS7iwCXqL89JkPOY3DY-4Qumz76_1jy4Z8ZbvTBOzse8Yx0iHMKC0kDhoTh5sf69vXroCWvtQL5B4nKrGs</recordid><startdate>20170801</startdate><enddate>20170801</enddate><creator>Anagnostis, Panagiotis</creator><creator>Paschou, Stavroula A</creator><creator>Mintziori, Gesthimani</creator><creator>Ceausu, Iuliana</creator><creator>Depypere, Herman</creator><creator>Lambrinoudaki, Irene</creator><creator>Mueck, Alfred</creator><creator>Pérez-López, Faustino R</creator><creator>Rees, Margaret</creator><creator>Senturk, Levent M</creator><creator>Simoncini, Tommaso</creator><creator>Stevenson, John C</creator><creator>Stute, Petra</creator><creator>Trémollieres, Florence A</creator><creator>Goulis, Dimitrios G</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170801</creationdate><title>Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al</title><author>Anagnostis, Panagiotis ; Paschou, Stavroula A ; Mintziori, Gesthimani ; Ceausu, Iuliana ; Depypere, Herman ; Lambrinoudaki, Irene ; Mueck, Alfred ; Pérez-López, Faustino R ; Rees, Margaret ; Senturk, Levent M ; Simoncini, Tommaso ; Stevenson, John C ; Stute, Petra ; Trémollieres, Florence A ; Goulis, Dimitrios G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c372t-f62c8c7c4f335325233cb8dad21c30d1216abb617512ef13a8ff143a123c0e973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Internal Medicine</topic><topic>Obstetrics and Gynecology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Anagnostis, Panagiotis</creatorcontrib><creatorcontrib>Paschou, Stavroula A</creatorcontrib><creatorcontrib>Mintziori, Gesthimani</creatorcontrib><creatorcontrib>Ceausu, Iuliana</creatorcontrib><creatorcontrib>Depypere, Herman</creatorcontrib><creatorcontrib>Lambrinoudaki, Irene</creatorcontrib><creatorcontrib>Mueck, Alfred</creatorcontrib><creatorcontrib>Pérez-López, Faustino R</creatorcontrib><creatorcontrib>Rees, Margaret</creatorcontrib><creatorcontrib>Senturk, Levent M</creatorcontrib><creatorcontrib>Simoncini, Tommaso</creatorcontrib><creatorcontrib>Stevenson, John C</creatorcontrib><creatorcontrib>Stute, Petra</creatorcontrib><creatorcontrib>Trémollieres, Florence A</creatorcontrib><creatorcontrib>Goulis, Dimitrios G</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Maturitas</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Anagnostis, Panagiotis</au><au>Paschou, Stavroula A</au><au>Mintziori, Gesthimani</au><au>Ceausu, Iuliana</au><au>Depypere, Herman</au><au>Lambrinoudaki, Irene</au><au>Mueck, Alfred</au><au>Pérez-López, Faustino R</au><au>Rees, Margaret</au><au>Senturk, Levent M</au><au>Simoncini, Tommaso</au><au>Stevenson, John C</au><au>Stute, Petra</au><au>Trémollieres, Florence A</au><au>Goulis, Dimitrios G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al</atitle><jtitle>Maturitas</jtitle><addtitle>Maturitas</addtitle><date>2017-08-01</date><risdate>2017</risdate><volume>102</volume><spage>76</spage><epage>77</epage><pages>76-77</pages><issn>0378-5122</issn><eissn>1873-4111</eissn><cop>Ireland</cop><pub>Elsevier B.V</pub><pmid>28483346</pmid><doi>10.1016/j.maturitas.2017.04.019</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0378-5122
ispartof Maturitas, 2017-08, Vol.102, p.76-77
issn 0378-5122
1873-4111
language eng
recordid cdi_proquest_miscellaneous_1896894374
source ScienceDirect Freedom Collection 2022-2024
subjects Internal Medicine
Obstetrics and Gynecology
title Bisphosphonates or denosumab discontinuation and risk of fractures: Response to the Letter by Anastasilakis et al
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T20%3A54%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Bisphosphonates%20or%20denosumab%20discontinuation%20and%20risk%20of%20fractures:%20Response%20to%20the%20Letter%20by%20Anastasilakis%20et%20al&rft.jtitle=Maturitas&rft.au=Anagnostis,%20Panagiotis&rft.date=2017-08-01&rft.volume=102&rft.spage=76&rft.epage=77&rft.pages=76-77&rft.issn=0378-5122&rft.eissn=1873-4111&rft_id=info:doi/10.1016/j.maturitas.2017.04.019&rft_dat=%3Cproquest_cross%3E1896894374%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c372t-f62c8c7c4f335325233cb8dad21c30d1216abb617512ef13a8ff143a123c0e973%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1896894374&rft_id=info:pmid/28483346&rfr_iscdi=true